Peroxisome proliferator-activated receptor (PPAR) α or γ does not change ischemic tolerance in hearts from type 2 diabetic mice.

被引：0
|
作者：
Aasum, E
Carley, A
Larsen, TS
Severson, DL
机构：
[1] Univ Tromso, N-9001 Tromso, Norway
[2] Univ Calgary, Calgary, AB T2N 1N4, Canada
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2002年 / 34卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [21] Differential splicing of the human peroxisome proliferator-activated receptor, PPARβ/δ
    Su, Shengzhong
    Omiecinski, Curtis J.
    FASEB JOURNAL, 2007, 21 (05): : A419 - A419
  • [22] Peroxisome proliferator-activated receptor (PPAR) modulators: Diabetes and beyond
    Jones, AB
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 540 - 552
  • [23] Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes
    Abdallah, Hossam M.
    El Dine, Riham Salah
    Mohamed, Gamal A.
    Ibrahim, Sabrin R. M.
    Shehata, Ibrahim A.
    El-Halawany, Ali M.
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 : 28 - 44
  • [24] Peroxisome proliferator-activated receptor (PPAR)-alpha/gamma agonism enhances arteriogenesis in mice
    Werner, C.
    Schirmer, S. H.
    Boehm, M.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1122 - 1123
  • [25] Role of Peroxisome Proliferator-Activated Receptor a in Diabetic Nephropathy
    Chung, Sungjin
    Park, Cheol Whee
    DIABETES & METABOLISM JOURNAL, 2011, 35 (04) : 327 - 336
  • [26] Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
    Girroir, Elizabeth E.
    Hollingshead, Holly E.
    He, Pengfei
    Zhu, Bokai
    Perdew, Gary H.
    Peters, Jeffrey M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 371 (03) : 456 - 461
  • [27] Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
    Maria Quintela, Ana
    Jimenez, Rosario
    Gomez-Guzman, Manuel
    Jose Zarzuelo, Maria
    Galindo, Pilar
    Sanchez, Manuel
    Vargas, Felix
    Cogolludo, Angel
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Duarte, Juan
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) : 730 - 741
  • [28] Peroxisome proliferator-activated receptor (PPAR)-α agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats:: A comparison with PPARγ agonism
    Bergeron, Raynald
    Yao, Jun
    Woods, John W.
    Zycband, Emanuel I.
    Liu, Cherrie
    Li, Zhihua
    Adams, Alan
    Berger, Joel P.
    Zhang, Bei B.
    Moller, David E.
    Doebber, Thomas W.
    ENDOCRINOLOGY, 2006, 147 (09) : 4252 - 4262
  • [29] Effects of peroxisome proliferator-activated receptor (PPAR)-γ ligands, pioglitazone, on endothelial function and nitrate tolerance in type 2 diabetics with stable
    Watanabe, H
    Nakagawa, K
    Kakihana, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 389A - 389A
  • [30] Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria
    Mahmut Ilker Yilmaz
    Alper Sonmez
    Kayser Caglar
    Deniz Engin Gok
    Tayfun Eyileten
    Müjdat Yenicesu
    Cengizhan Acikel
    Necati Bingol
    Selim Kilic
    Yusuf Oguz
    Abdulgaffar Vural
    Endocrine, 2004, 25 : 207 - 214
12345